Skip to main content
SpringerLink
Log in

Determination of brain iron content in patients with Parkinson’s disease using magnetic susceptibility imaging

磁敏感成像检测帕金森氏病脑铁沉积

  • Original Article
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

Abstract

Objective

To compare the phase radians in several cerebral regions between patients with Parkinson’s disease (PD) and control subjects, and to evaluate whether iron deposition quantified by susceptibility-weighted imaging (SWI) is related to the severity of motor symptoms of PD.

Methods

SWI consisted of both magnitude and phase images from a fully flow-compensated, 3-dimensional and gradient-echo (GRE) sequence. Magnitude and phase data were collected at GE HD 1.5T. The regions evaluated included frontal white matter, grey matter, cerebrospinal fluid, putamen, caudate nucleus (CN), substantia nigra pars compacta (SNc), substantia nigra pars reticulata (SNr), and red nucleus (RN). A total number of 42 patients (12 patients without cognitive dysfunction, and 30 with cognitive dysfunction from mild to moderate degrees) and 30 control subjects were employed in the present study.

Results

The phase radians of SNc, CN and RN in PD patients were lower than those in control subjects (P<0.05).

Conclusion

The phase radians can be used to estimate the brain iron deposition in PD patients, which may be helpful in the diagnosis and longitudinal monitoring of PD.

摘要

目的

比较帕金森氏病(Parkinson’s disease, PD)患者和健康对照者多个脑结构的相位偏移值(phase radians), 探讨相位偏移值的临床应用价值。

方法

42 名PD患者及30 名年龄匹配的健康对照者均在1.5 T MR系统中进行头部检查。 所有PD 患者均存在轻度到中度认知功能缺损。 采用磁敏感成像获得相位图, 测量双侧尾状核、 壳核、 黑质致密带、 黑质网状带、 红核、 脑脊液、 额叶白质及额叶灰质内所感兴趣区的相位偏移值。

结果

与正常对照组相比, PD组黑质致密带的相位偏移值均数显著缩短(P < 0.05)。 此外, PD组双侧尾状核和红核的相位偏移值亦显著降低(P < 0.05), 而黑质网状带的相位偏移值与对照组相比无统计学差异(P > 0.05)。

结论

通过对相位偏移值的测定可以估测PD 患者脑内的铁沉积, 为PD 的活体诊断及病情监测提供帮助。

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schapira AH. Etiology of Parkinson’s disease. Neurology 2006, 66: S10–23.

    PubMed  Google Scholar 

  2. Taylor KC, Counsell C. Is it Parkinson’s disease, and if not, what is it? Pract Neurol 2006, 6: 154–165.

    Article  Google Scholar 

  3. Griffiths PD, Dobson BR, Jones GR, Clarke DT. Iron in the basal ganglia in Parkinson’s disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain 1999, 122(Pt 4): 667–673.

    Article  PubMed  Google Scholar 

  4. Kosta P, Argyropoulou MI, Markoula S, Konitsiotis S. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson’s disease. J Neurol 2006, 253: 26–32.

    Article  PubMed  Google Scholar 

  5. Haacke EM, Cheng NY, House MJ, Liu Q, Neelavalli J, Ogg RJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005, 23: 1–25.

    Article  CAS  PubMed  Google Scholar 

  6. Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, Carter M, et al. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol Aging 2007, 28: 414–423.

    Article  CAS  PubMed  Google Scholar 

  7. Berg D, Gerlach M, Youdim M, Villablanca P, Altshuler LL, Carter M, et al. Brain iron pathways and their relevance to Parkinson’s disease. J Neurochem 2001, 79: 225–236.

    Article  CAS  PubMed  Google Scholar 

  8. Gotz M, Double K, Gerlach M, Youdim M, Riederer P. The relevance of iron in the pathogenesis of Parkinson’s disease. Ann N Y Acad Sci 2004, 1012: 193–208.

    Article  PubMed  Google Scholar 

  9. Michell A, Lewis S, Foltynie T, Barker R. Biomarkers and Parkinson’s disease. Ann Neurol 2004, 35: 204–210.

    Google Scholar 

  10. Bartzokis G, Tishler TA, Shin IS, Lu PH, Cummings JL. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann N Y Acad Sci 2004, 1012: 224–236.

    Article  CAS  PubMed  Google Scholar 

  11. Sadrzadeh SM, Saffari Y. Iron and brain disorders. Am J Clin Pathol 2004, 121: S64–S70.

    Article  PubMed  Google Scholar 

  12. Sipe JC, Lee P, Beutler E. Brain iron metabolism and neurodegenerative disorders. Dev Neurosci 2002, 24: 188–196.

    Article  CAS  PubMed  Google Scholar 

  13. Vermersch P, Leys D, Pruvo JP, Clarisse J, Petit H. Parkinson’s disease and basal ganglia calcifications: prevalence and clinicoradiological correlations. Clin Neurol Neurosurg 1992, 94: 213–217.

    Article  CAS  PubMed  Google Scholar 

  14. Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med 2004, 52: 612–618.

    Article  PubMed  Google Scholar 

  15. Ogg RJ, Langston JW, Haacke EM, Steen RG, Taylor JS. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 1999, 17: 1141–1148.

    Article  CAS  PubMed  Google Scholar 

  16. Tong KA, Ashwal S, Holshouser BA, Shutter LA, Herigault G, Haacke EM. Hemorrhagic shearing lesions in children and adolescents with posttraumatic diffuse axonal injury: improved detection and initial results. Radiology 2003, 227: 332–339.

    Article  PubMed  Google Scholar 

  17. Wang Y, Yu Y, Li D, Bae KT, Brown JJ, Lin W, et al. Artery and vein separation using susceptibility-dependent phase in contrastenhanced MRA. J Magn Reson Imaging 2000, 12: 661–670.

    Article  CAS  PubMed  Google Scholar 

  18. Reichenbach JR, Venkatesan R, Yablonskiy DA, Thompson MR, Lai S, Haacke EM. Theory and application of static field inhomogeneity effects in gradient-echo imaging. J Magn Reson Imaging 1997, 7: 266–279.

    Article  CAS  PubMed  Google Scholar 

  19. Gurleyik K, Haacke EM. Quantification of errors in volume measurements of the caudate nucleus using magnetic resonance imaging. Magn Reson Imaging 2002, 15: 353–363.

    Article  Google Scholar 

  20. Martin WR, Wieler M, Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008, 70: 1411–1417.

    Article  CAS  PubMed  Google Scholar 

  21. Schenck JF, Zimmerman EA. High-field magnetic resonance imaging of brain iron: birth of a biomarker? NMR Biomed 2004, 17(7): 433–445.

    Article  CAS  PubMed  Google Scholar 

  22. Vymazal J, Righini A, Brooks RA, Canesi M, Mariani C, Leonardi M, et al. T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 1999, 211: 489–495.

    CAS  PubMed  Google Scholar 

  23. Philippe Ryvlin, Emmanuel Broussolle, Henri Piollet, Francois Viallet, Yad Khalfallah, Guy Chazot. Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson’s disease. Arch Neurol. 1995;52:583–588.

    Google Scholar 

  24. Graham JM, Paley MN, Grunewald RA, Hoggard N, Griffiths PD. Brain iron deposition in Parkinson’s disease imaged using the PRIME magnetic resonance sequence. Brain 2000, 123(Pt 12): 2423–2431.

    Article  PubMed  Google Scholar 

  25. Levy R, Hazrati LN, Herrero MT, Vila M, Hassani OK, Mouroux M, et al. Re-evaluation of the functional anatomy of the basal ganglia in normal and Parkinsonian states. Neuroscience 1997, 76(2): 335–343.

    Article  CAS  PubMed  Google Scholar 

  26. Griffiths PD, Crossman AR. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson’s disease and Alzheimer’s disease. Dementia 1993, 4: 61–65.

    CAS  PubMed  Google Scholar 

  27. Wallis LI, Paley MN, Graham JM, Grünewald RA, Wignall EL, Joy HM, et al. MRI assessment of basal ganglia iron deposition in Parkinson’s disease. J Magn Reson Imaging 2008, 28(5): 1061–1067.

    Article  PubMed  Google Scholar 

  28. Atasoy HT, Nuyan O, Tunc T, Yorubulut M, Unal AE, Inan LE. T2-weighted MRI in Parkinson’s disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. Neurol India 2004, 52(3): 332–337.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Wei Zhang  (张蔚), Sheng-Gan Sun  (孙圣刚), Xian Qiao  (乔娴), Xin Sun  (孙欣) & Yan Wu  (吴艳)

  2. Department of Radiology, Wuhan Chinese and Western Medicine Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Wei Zhang  (张蔚) & Yu-Hong Jiang  (蒋宇宏)

Authors
  1. Wei Zhang  (张蔚)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sheng-Gan Sun  (孙圣刚)
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yu-Hong Jiang  (蒋宇宏)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xian Qiao  (乔娴)
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xin Sun  (孙欣)
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yan Wu  (吴艳)
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei Zhang  (张蔚).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, W., Sun, SG., Jiang, YH. et al. Determination of brain iron content in patients with Parkinson’s disease using magnetic susceptibility imaging. Neurosci. Bull. 25, 353–360 (2009). https://doi.org/10.1007/s12264-009-0225-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-009-0225-8

Keywords

CLC number

关键词

Search

Navigation